Predictive Oncology (FRA:S1K) Change In Receivables : €-0.21 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Predictive Oncology Change In Receivables?

Predictive Oncology's change in receivables for the quarter that ended in Mar. 2024 was €-0.16 Mil. It means Predictive Oncology's Accounts Receivable increased by €0.16 Mil from Dec. 2023 to Mar. 2024 .

Predictive Oncology's change in receivables for the fiscal year that ended in Dec. 2023 was €-0.00 Mil. It means Predictive Oncology's Accounts Receivable increased by €0.00 Mil from Dec. 2022 to Dec. 2023 .

Predictive Oncology's Accounts Receivable for the quarter that ended in Mar. 2024 was €0.47 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Predictive Oncology's Days Sales Outstanding for the three months ended in Mar. 2024 was 110.63.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Predictive Oncology's liquidation value for the three months ended in Mar. 2024 was €-0.69 Mil.

Predictive Oncology Change In Receivables Historical Data

The historical data trend for Predictive Oncology's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predictive Oncology Change In Receivables Chart

Predictive Oncology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

0.13

0.06

-0.02

0.02

Predictive Oncology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															0.05	-0.14	-0.11	0.19	-0.16

Predictive Oncology Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.21 Mil.

Predictive Oncology (FRA:S1K) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Predictive Oncology's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.468	/	0.386	*	91
=	110.63

2. In Ben Graham's calculation of liquidation value, Predictive Oncology's accounts receivable are only considered to be worth 75% of book value:

Predictive Oncology's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	4.781	-	6.024	+	0.75 * 0.468	+	0.5 * 0.407
=	-0.69

Predictive Oncology Change In Receivables Related Terms

Thank you for viewing the detailed overview of Predictive Oncology's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Predictive Oncology (FRA:S1K) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Predictive Oncology Inc (FRA:S1K) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

POAI:USA

Address

2915 Commers Drive, Suite 900, Eagan, MN, USA, 55121

Website

https://www.predictive-oncology.com

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response.

Predictive Oncology (FRA:S1K) Headlines

No Headlines